The Pseudomonas aeruginosa PsrA responds to long-chain fatty acid signals to regulate the fadBA5 b-oxidation operon b-Oxidative enzymes for fatty acid degradation (Fad) of long-chain fatty acids (LCFAs) are induced in vivo during lung infection in cystic fibrosis patients, and this may contribute to nutrient acquisition and pathogenesis of Pseudomonas aeruginosa. The promoter region of one P. aeruginosa b-oxidation operon, fadBA5 (PA3014 and PA3013), was mapped. Focusing on the transposon mutagenesis of strain PAO1 carrying the P fadBA5 -lacZ fusion, a regulator for the fadBA5 operon was identified to be PsrA (PA3006). Transcriptome analysis of the DpsrA mutant indicated its importance in regulating b-oxidative enzymes. These microarray data were confirmed by real-time RT-PCR analyses of the fadB5 and lipA (encoding a lipase) genes. Induction of the fadBA5 operon was demonstrated to respond to novel LCFA signals, and this induction required the presence of PsrA, suggesting that LCFAs bind to PsrA to derepress fadBA5. Electrophoretic mobility shift assays indicate specific binding of PsrA to the fadBA5 promoter region. This binding is disrupted by specific LCFAs (C 18 : 1 D9 , C 16 : 0 , C 14 : 0 and, to a lesser extent, C 12 : 0 ), but not by other medium-or short-chain fatty acids or the first intermediate of b-oxidation, acyl-CoA. It is shown here that PsrA is a fadBA5 regulator that binds and responds to LCFA signals in P. aeruginosa.
INTRODUCTIONPseudomonas aeruginosa is an opportunistic pathogen, and the spectrum of infections and diseases it causes is second to none. P. aeruginosa can cause infections of the ear, bone, joint, skin and soft tissue, and more serious infections, including meningitis, bacteraemia, endocarditis, ocular infections, hospital-acquired pneumonia, and lung infections in cystic fibrosis (CF) patients (Baltch & Griffin, 1977;Bowton, 1999;Fleiszig et al., 1995;Greenberger, 1997;Lode et al., 2000;Pruitt et al., 1998;Reyes & Lerner, 1983;Richards et al., 1999;Schaberg et al., 1991). P. aeruginosa lung infections transpire in nosocomial pneumonia and in CF patients. Nosocomial pneumonia is the second most common of all nosocomial infections, and P. aeruginosa has been the most frequently isolated microbe responsible (Pennington, 1994;Richards et al., 1999). In addition, over 93 % of CF patients between the ages of 18 and 24 have been infected with P. aeruginosa (Doring, 1997).Fatty acid degradation (Fad) pathways may play critical roles in P. aeruginosa pathogenesis. It has recently been demonstrated that the Fad pathways of P. aeruginosa may have important implications in nutrient acquisition and pathogenesis within the CF lung (Son et al., 2007), through the degradation of an essential lung surfactant component phosphatidylcholine (PC). The degradation of one PC component, long-chain fatty acid (LCFA), potentially occurs through three different b-oxidation pathways, involving three fadBA operons (fadAB1, PA1737 and PA1736; fadAB4, PA4786 and PA4785; and fadBA5, PA3014 and PA3013) (Son e...